Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression changes induced by the human aristolochic acid I in renal and hepatic tissue of mice


ABSTRACT: Aristolochic acid (AA) is the causative agent of urothelial tumours associated with aristolochic acid nephropathy and is also implicated in the development of Balkan endemic nephropathy-associated urothelial tumours. These tumours contain AA-characteristic TP53 mutations. We examined gene expression changes in Hupki (human TP53 knock-in) mice after treatment with aristolochic acid I (AAI) by gavage (5 mg/kg body weight). After 3, 12 and 21 days of treatment gene expression profiles were investigated using Agilent Whole Mouse 44K Genome Oligo Array. Expression profiles were significantly altered by AAI treatment in both target (kidney) and non-target (liver) tissue. Renal pathology and DNA adduct analysis confirmed kidney as the target tissue of AAI-induced toxicity. Gene ontology for functional analysis revealed that processes related to apoptosis, cell cycle, stress response, immune system, inflammatory response and kidney development were altered in kidney. Canonical pathway analysis indicated Nfkb, aryl hydrocarbon receptor, Tp53 and cell cycle signalling as the most important pathways modulated in kidney. Expression of Nfkb1 and other Nfkb-target genes was confirmed by quantitative real-time PCR (qRT-PCR) and was consistent with the induction of Nfkb1 protein. Myc oncogene, frequently over-expressed in urothelial tumours, was up-regulated by AAI on the microarrays and confirmed by qRT-PCR and protein induction. Collectively we found that microarray gene expression analysis is a useful tool to define tissue-specific responses in AAI-induced toxicity. Several genes identified such as TP53, Rb1, Mdm2, Cdkn2a and Myc are frequently affected in human urothelial cancer, and may be valuable prognostic markers in future clinical studies. Keywords: Carcinogen treatment Two-color Agilent array. A reference design was chosen that all samples were hybridised to universal mouse reference RNA (UMRR). 12-condition experiment (2 mouse organs: kidney and liver; 2 treatments: AAI and water; 3 time points: 3, 12 and 21 days). Three biological replicates for each condition. One replicate per array.

ORGANISM(S): Mus musculus

SUBMITTER: Ian Giddings 

PROVIDER: E-GEOD-18246 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.

Arlt Volker M VM   Zuo Jie J   Trenz Kristina K   Roufosse Candice A CA   Lord Graham M GM   Nortier Joelle L JL   Schmeiser Heinz H HH   Hollstein Monica M   Phillips David H DH  

International journal of cancer 20110101 1


Aristolochic acid (AA) is the causative agent of urothelial tumors associated with AA nephropathy and is also implicated in the development of Balkan endemic nephropathy-associated urothelial tumors. These tumors contain AA-characteristic TP53 mutations. We examined gene expression changes in Hupki (human TP53 knock-in) mice after treatment with aristolochic acid I (AAI) by gavage (5 mg/kg body weight). After 3, 12 and 21 days of treatment gene expression profiles were investigated using Agilent  ...[more]

Similar Datasets

2010-06-09 | GSE18246 | GEO
2014-01-09 | E-GEOD-53911 | biostudies-arrayexpress
2010-09-24 | E-GEOD-18243 | biostudies-arrayexpress
2014-01-09 | GSE53911 | GEO
2021-06-23 | E-MTAB-9390 | biostudies-arrayexpress
2018-05-09 | GSE101530 | GEO
2009-02-28 | E-GEOD-11578 | biostudies-arrayexpress
2024-02-03 | GSE254440 | GEO
2015-07-02 | E-GEOD-68687 | biostudies-arrayexpress
2016-03-10 | E-GEOD-79063 | biostudies-arrayexpress